Reaction

Hypermetabolism reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 519 reports · 12 co-occurring drugs

As of the last recalculation, Hypermetabolism appears in 519 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is FULVESTRANT (PRR 33.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Fulvestrant2633.233.2
Isoniazid1230.430.4
Lisdexamfetamine Dimesylate2126.626.6
Pyrazinamide625.925.9
Rifampin925.125.2
Rifampicin624.124.1
Naltrexone1520.120.1
Paliperidone Palmitate1519.219.2
Alpelisib418.518.5
Pertuzumab1116.616.6
Lurasidone Hydrochloride815.615.6
Polatuzumab Vedotin312.412.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.